NL6406797A - - Google Patents

Info

Publication number
NL6406797A
NL6406797A NL6406797A NL6406797A NL6406797A NL 6406797 A NL6406797 A NL 6406797A NL 6406797 A NL6406797 A NL 6406797A NL 6406797 A NL6406797 A NL 6406797A NL 6406797 A NL6406797 A NL 6406797A
Authority
NL
Netherlands
Application number
NL6406797A
Other versions
NL146383B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE665514D priority Critical patent/BE665514A/xx
Application filed filed Critical
Priority to NL646406797A priority patent/NL146383B/xx
Priority to US460476A priority patent/US3340279A/en
Priority to GB23737/65A priority patent/GB1104462A/en
Priority to CH814865A priority patent/CH517725A/de
Priority to DK297965AA priority patent/DK114553B/da
Priority to SE07832/65A priority patent/SE336788B/xx
Priority to DE1543273A priority patent/DE1543273C3/de
Priority to BR170429/65A priority patent/BR6570429D0/pt
Priority to FR21055A priority patent/FR1594513A/fr
Publication of NL6406797A publication Critical patent/NL6406797A/xx
Publication of NL146383B publication Critical patent/NL146383B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL646406797A 1964-06-16 1964-06-16 Werkwijze ter bereiding van anabool werkzame 7alfa-methyl-steroiden van de oestraanreeks, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat. NL146383B (nl)

Priority Applications (10)

Application Number Priority Date Filing Date Title
BE665514D BE665514A (de) 1964-06-16
NL646406797A NL146383B (nl) 1964-06-16 1964-06-16 Werkwijze ter bereiding van anabool werkzame 7alfa-methyl-steroiden van de oestraanreeks, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat.
US460476A US3340279A (en) 1964-06-16 1965-06-01 7alpha-methyl-steroids of the oestrane series
GB23737/65A GB1104462A (en) 1964-06-16 1965-06-03 7ª‡-methyl-steroids of the oestrane series
CH814865A CH517725A (de) 1964-06-16 1965-06-11 Verfahren zur Herstellung von 7a-Methylsteroiden
DK297965AA DK114553B (da) 1964-06-16 1965-06-14 Fremgangsmåde til fremstilling af biologisk aktive 7α-methyl-3-keto-Δ<5(10)>-østrener.
SE07832/65A SE336788B (de) 1964-06-16 1965-06-14
DE1543273A DE1543273C3 (de) 1964-06-16 1965-06-15 7 alpha-Methyl-Delta hoch 5(16) -steroide der Oestranreihe und Verfahren zu deren Herstellung
BR170429/65A BR6570429D0 (pt) 1964-06-16 1965-06-15 Processo para preparar 7-alfa metil esteroides da serie da estrama
FR21055A FR1594513A (de) 1964-06-16 1965-06-16

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL646406797A NL146383B (nl) 1964-06-16 1964-06-16 Werkwijze ter bereiding van anabool werkzame 7alfa-methyl-steroiden van de oestraanreeks, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat.

Publications (2)

Publication Number Publication Date
NL6406797A true NL6406797A (de) 1965-12-17
NL146383B NL146383B (nl) 1975-07-15

Family

ID=19790312

Family Applications (1)

Application Number Title Priority Date Filing Date
NL646406797A NL146383B (nl) 1964-06-16 1964-06-16 Werkwijze ter bereiding van anabool werkzame 7alfa-methyl-steroiden van de oestraanreeks, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat.

Country Status (10)

Country Link
US (1) US3340279A (de)
BE (1) BE665514A (de)
BR (1) BR6570429D0 (de)
CH (1) CH517725A (de)
DE (1) DE1543273C3 (de)
DK (1) DK114553B (de)
FR (1) FR1594513A (de)
GB (1) GB1104462A (de)
NL (1) NL146383B (de)
SE (1) SE336788B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875188A (en) * 1968-04-10 1975-04-01 Eugene E Galantay 17-Beta-alpha-lower alkyl allene-substituted steroids
BE755689A (fr) * 1969-09-03 1971-03-03 Upjohn Co Procede de fabrication de nouvelles 7 beta-alkyl-19- nortestosterones
US3997664A (en) * 1971-02-09 1976-12-14 Sandoz, Inc. Substituted carbinol derivatives
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
CN100432093C (zh) * 1998-10-16 2008-11-12 欧加农股份有限公司 包含（7α,17α)-17-羟基-7-甲基-19-去甲-17-孕-5（10）-烯-20-炔-3-酮的高纯度组合物
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
KR20050038590A (ko) * 2003-05-23 2005-04-27 엔.브이. 오가논 다형성 티볼론을 포함하는 즉시-방출형 약학 제형
EP1872775A1 (de) * 2006-06-29 2008-01-02 Polichem S.A. Verwendung einer hydrophilen Matrix, die ein Polyacrylsäurederivat, einen Celluloseether und ein Zerfallsmittel enthält, für die Herstellung eines Medikamentes zur Behandlung weiblicher Genitalstörungen
EP3452019B1 (de) 2016-05-04 2021-06-23 Novalon S.A. Verwendung von zuckeralkoholen in tibolonzusammensetzungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2725389A (en) * 1953-08-31 1955-11-29 Searle & Co 13-methyl-17-ethynyl-17-hydroxy-1, 2, 3, 4, 6, 7, 8, 9, 11, 12, 13, 14, 16, 17-tetradecahydro15h-cyclopenta [a] phenanthren-3-one and its preparation
US3262949A (en) * 1956-11-13 1966-07-26 Syntex Corp 7-methyl androstane compounds
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process

Also Published As

Publication number Publication date
DK114553B (da) 1969-07-14
GB1104462A (en) 1968-02-28
NL146383B (nl) 1975-07-15
DE1543273B2 (de) 1973-07-05
BR6570429D0 (pt) 1973-08-14
DE1543273C3 (de) 1974-02-21
DE1543273A1 (de) 1969-08-07
BE665514A (de)
SE336788B (de) 1971-07-19
FR1594513A (de) 1970-06-08
CH517725A (de) 1972-01-15
US3340279A (en) 1967-09-05

Similar Documents

Publication Publication Date Title
FR1594513A (de)
AU442366B2 (de)
BE642470A (de)
BE554195A (de)
BE613833A (de)
BE660928A (de)
BE660821A (de)
BE660621A (de)
BE610935A (de)
BE603534A (de)
BE584699A (de)
BE660588A (de)
BE564626A (de)
BE659689A (de)
BE621510A (de)
BE518974A (de)
BE507097A (de)
BE659596A (de)
BE483969A (de)
BE47396A (de)
BE659590A (de)
BE659250A (de)
BE658849A (de)
BE658683A (de)
BE658085A (de)

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: ORGANON

V4 Discontinued because of reaching the maximum lifetime of a patent